Bala S. Manian - May 10, 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Bala S. Manian
Stock symbol
VCNX
Transactions as of
May 10, 2024
Transactions value $
$10,633
Form type
4
Date filed
5/14/2024, 04:33 PM
Previous filing
May 23, 2023
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $10.6K +2.69K $3.96 2.69K May 10, 2024 Common Stock 2.69K $5.75 Direct F6
transaction VCNX Stock Option (Right to Buy) Award $0 +10.1K $0.00 10.1K May 10, 2024 Common Stock 10.1K $5.75 Direct F7
holding VCNX Stock Option (Right to Buy) 36 May 10, 2024 Common Stock 36 $1,633.80 Direct F1
holding VCNX Stock Option (Right to Buy) 74 May 10, 2024 Common Stock 74 $829.50 Direct F2
holding VCNX Stock Option (Right to Buy) 136 May 10, 2024 Common Stock 136 $451.50 Direct F3
holding VCNX Stock Option (Right to Buy) 253 May 10, 2024 Common Stock 253 $235.20 Direct F4
holding VCNX Stock Option (Right to Buy) 684 May 10, 2024 Common Stock 684 $86.10 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F2 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F4 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F6 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $10,625 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
F7 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.

Remarks:

All figures in this Form 4 reflect the Issuer's 1-for-15 reverse stock split effected on September 25, 2023 and 1-for-14 reverse stock split effected on February 19, 2024.